首页 > 最新文献

Archives of internal medicine最新文献

英文 中文
Myocardial infarction and sudden cardiac death in Olmsted County, Minnesota, before and after smoke-free workplace laws. 明尼苏达州奥姆斯特德县的心肌梗死和心源性猝死,禁烟前后的工作场所。
Pub Date : 2012-11-26 DOI: 10.1001/2013.jamainternmed.46
Richard D Hurt, Susan A Weston, Jon O Ebbert, Sheila M McNallan, Ivana T Croghan, Darrell R Schroeder, Véronique L Roger

Background: Reductions in admissions for myocardial infarction (MI) have been reported in locales where smoke-free workplace laws have been implemented, but no study has assessed sudden cardiac death in that setting. In 2002, a smoke-free restaurant ordinance was implemented in Olmsted County, Minnesota, and in 2007, all workplaces, including bars, became smoke free.

Methods: To evaluate the population impact of smoke-free laws, we measured, through the Rochester Epidemiology Project, the incidence of MI and sudden cardiac death in Olmsted County during the 18-month period before and after implementation of each smoke-free ordinance. All MIs were continuously abstracted and validated, using rigorous standardized criteria relying on biomarkers, cardiac pain, and Minnesota coding of the electrocardiogram. Sudden cardiac death was defined as out-of-hospital deaths associated with coronary disease.

Results: Comparing the 18 months before implementation of the smoke-free restaurant ordinance with the 18 months after implementation of the smoke-free workplace law, the incidence of MI declined by 33% (P < .001), from 150.8 to 100.7 per 100,000 population, and the incidence of sudden cardiac death declined by 17% (P = .13), from 109.1 to 92.0 per 100,000 population. During the same period, the prevalence of smoking declined and that of hypertension, diabetes mellitus, hypercholesterolemia, and obesity either remained constant or increased.

Conclusions: A substantial decline in the incidence of MI was observed after smoke-free laws were implemented, the magnitude of which is not explained by community cointerventions or changes in cardiovascular risk factors with the exception of smoking prevalence. As trends in other risk factors do not appear explanatory, smoke-free workplace laws seem to be ecologically related to these favorable trends. Secondhand smoke exposure should be considered a modifiable risk factor for MI. All people should avoid secondhand smoke to the extent possible, and people with coronary heart disease should have no exposure to secondhand smoke.

背景:在实施无烟工作场所法律的地区,心肌梗死(MI)入院率有所下降,但没有研究评估该环境下的心源性猝死。2002年,明尼苏达州奥姆斯特德县实施了一项无烟餐厅条例,2007年,包括酒吧在内的所有工作场所都禁止吸烟。方法:为了评估无烟法律对人群的影响,我们通过罗切斯特流行病学项目测量了奥姆斯特德县在每个无烟法令实施前后18个月期间心肌梗死和心源性猝死的发生率。使用严格的标准化标准,根据生物标志物、心脏疼痛和明尼苏达州心电图编码,持续提取和验证所有MIs。心源性猝死定义为与冠状动脉疾病相关的院外死亡。结果:《餐厅无烟条例》实施前18个月与《工作场所无烟法》实施后18个月相比,心肌梗死发生率从150.8 / 10万人下降到100.7 / 10万人,下降了33% (P < 0.001);心源性猝死发生率从109.1 / 10万人下降到92.0 / 10万人,下降了17% (P = 0.13)。在同一时期,吸烟的患病率下降,而高血压、糖尿病、高胆固醇血症和肥胖的患病率保持不变或增加。结论:在实施无烟法律后,观察到心肌梗死发生率大幅下降,其幅度不能用社区共同干预或除吸烟流行外心血管危险因素的变化来解释。由于其他风险因素的趋势似乎无法解释,无烟工作场所法律似乎与这些有利趋势有生态关系。二手烟暴露应被视为心肌梗死可改变的危险因素。所有人都应尽可能避免二手烟,冠心病患者不应接触二手烟。
{"title":"Myocardial infarction and sudden cardiac death in Olmsted County, Minnesota, before and after smoke-free workplace laws.","authors":"Richard D Hurt,&nbsp;Susan A Weston,&nbsp;Jon O Ebbert,&nbsp;Sheila M McNallan,&nbsp;Ivana T Croghan,&nbsp;Darrell R Schroeder,&nbsp;Véronique L Roger","doi":"10.1001/2013.jamainternmed.46","DOIUrl":"https://doi.org/10.1001/2013.jamainternmed.46","url":null,"abstract":"<p><strong>Background: </strong>Reductions in admissions for myocardial infarction (MI) have been reported in locales where smoke-free workplace laws have been implemented, but no study has assessed sudden cardiac death in that setting. In 2002, a smoke-free restaurant ordinance was implemented in Olmsted County, Minnesota, and in 2007, all workplaces, including bars, became smoke free.</p><p><strong>Methods: </strong>To evaluate the population impact of smoke-free laws, we measured, through the Rochester Epidemiology Project, the incidence of MI and sudden cardiac death in Olmsted County during the 18-month period before and after implementation of each smoke-free ordinance. All MIs were continuously abstracted and validated, using rigorous standardized criteria relying on biomarkers, cardiac pain, and Minnesota coding of the electrocardiogram. Sudden cardiac death was defined as out-of-hospital deaths associated with coronary disease.</p><p><strong>Results: </strong>Comparing the 18 months before implementation of the smoke-free restaurant ordinance with the 18 months after implementation of the smoke-free workplace law, the incidence of MI declined by 33% (P < .001), from 150.8 to 100.7 per 100,000 population, and the incidence of sudden cardiac death declined by 17% (P = .13), from 109.1 to 92.0 per 100,000 population. During the same period, the prevalence of smoking declined and that of hypertension, diabetes mellitus, hypercholesterolemia, and obesity either remained constant or increased.</p><p><strong>Conclusions: </strong>A substantial decline in the incidence of MI was observed after smoke-free laws were implemented, the magnitude of which is not explained by community cointerventions or changes in cardiovascular risk factors with the exception of smoking prevalence. As trends in other risk factors do not appear explanatory, smoke-free workplace laws seem to be ecologically related to these favorable trends. Secondhand smoke exposure should be considered a modifiable risk factor for MI. All people should avoid secondhand smoke to the extent possible, and people with coronary heart disease should have no exposure to secondhand smoke.</p>","PeriodicalId":8290,"journal":{"name":"Archives of internal medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2012-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/2013.jamainternmed.46","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31011752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 80
Infecting the electrocardiogram. 感染了心电图。
Pub Date : 2012-11-26 DOI: 10.1001/archinternmed.2012.3740
Mary Fredrickson, Yader Sandoval, Woubeshet Ayenew
Mary Fredrickson, MD; Yader Sandoval, MD; Woubeshet Ayenew, MD; Department of Medicine (Drs Fredrickson and Sandoval) and Division of Cardiology (Dr Ayenew), Hennepin County Medical Center, Minneapolis, Minnesota A 60-YEAR-OLD MAN WITH NO KNOWN MEDIcal history was admitted to our emergency department following an episode of syncope. The patient was at work when he suddenly developed tunnel vision and
{"title":"Infecting the electrocardiogram.","authors":"Mary Fredrickson,&nbsp;Yader Sandoval,&nbsp;Woubeshet Ayenew","doi":"10.1001/archinternmed.2012.3740","DOIUrl":"https://doi.org/10.1001/archinternmed.2012.3740","url":null,"abstract":"Mary Fredrickson, MD; Yader Sandoval, MD; Woubeshet Ayenew, MD; Department of Medicine (Drs Fredrickson and Sandoval) and Division of Cardiology (Dr Ayenew), Hennepin County Medical Center, Minneapolis, Minnesota A 60-YEAR-OLD MAN WITH NO KNOWN MEDIcal history was admitted to our emergency department following an episode of syncope. The patient was at work when he suddenly developed tunnel vision and","PeriodicalId":8290,"journal":{"name":"Archives of internal medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2012-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/archinternmed.2012.3740","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31075811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Body mass index in 1.2 million adolescents and risk for end-stage renal disease. 120万青少年的体重指数与终末期肾脏疾病的风险
Pub Date : 2012-11-26 DOI: 10.1001/2013.jamainternmed.85
Asaf Vivante, Eliezer Golan, Dorit Tzur, Adi Leiba, Amir Tirosh, Karl Skorecki, Ronit Calderon-Margalit

Background: The relationship between adolescent body mass index (BMI) and future risk for end-stage renal disease (ESRD) is not fully understood, nor is it known the extent to which this association is limited to diabetic ESRD. We evaluated the association between BMI in adolescence and the risk for all-cause, diabetic, and nondiabetic ESRD.

Methods: Medical data about 1 194 704 adolescents aged 17 years who had been examined for fitness for military service between January 1, 1967, and December 31, 1997, were linked to the Israeli ESRD registry in this nationwide population-based retrospective cohort study. Incident cases of treated ESRD between January 1, 1980, and May 31, 2010, were included. Cox proportional hazards models were used to estimate the hazard ratio (HR) for treated ESRD among study participants for their BMI at age 17 years, defined in accord with the US Centers for Disease Control and Prevention BMI for age and sex classification.

Results: During 30 478 675 follow-up person-years (mean [SD], 25.51 [8.77] person-years), 874 participants (713 male and 161 female) developed treated ESRD, for an overall incidence rate of 2.87 cases per 100 000 person-years. Compared with adolescents of normal weight, overweight adolescents (85th to 95th percentiles of BMI) and obese adolescents (≥95th percentile of BMI) had an increased future risk for treated ESRD, with incidence rates of 6.08 and 13.40 cases per 100 000 person-years, respectively. In a multivariate model adjusted for sex, country of origin, systolic blood pressure, and period of enrollment in the study, overweight was associated with an HR of 3.00 (95% CI, 2.50-3.60) and obesity with an HR of 6.89 (95% CI, 5.52-8.59) for all-cause treated ESRD. Overweight (HR, 5.96; 95% CI, 4.41-8.06) and obesity (HR, 19.37; 95% CI, 14.13-26.55) were strong and independent risk factors for diabetic ESRD. Positive associations of overweight (HR, 2.17; 95% CI, 1.71-2.74) and obesity (HR, 3.41; 95% CI, 2.42-4.79) with nondiabetic ESRD were also documented.

Conclusions: Overweight and obesity in adolescents were associated with significantly increased risk for all-cause treated ESRD during a 25-year period. Elevated BMI constitutes a substantial risk factor for diabetic and nondiabetic ESRD.

背景:青少年身体质量指数(BMI)与终末期肾病(ESRD)未来风险之间的关系尚不完全清楚,也不清楚这种关联在多大程度上仅限于糖尿病性ESRD。我们评估了青春期BMI与全因、糖尿病和非糖尿病ESRD风险之间的关系。方法:在1967年1月1日至1997年12月31日期间,对1 194 704名17岁的青少年进行了兵役健康检查,这些青少年的医疗数据与以色列ESRD注册表相关联,这是一项基于全国人群的回顾性队列研究。纳入1980年1月1日至2010年5月31日期间接受治疗的ESRD事件病例。使用Cox比例风险模型来估计研究参与者在17岁时的BMI治疗ESRD的风险比(HR),其定义与美国疾病控制和预防中心年龄和性别分类的BMI一致。结果:在30 478 675人-年的随访期间(平均[SD], 25.51[8.77]人-年),874名参与者(713名男性,161名女性)发生了ESRD治疗,总发病率为2.87例/ 10万人-年。与正常体重的青少年相比,超重青少年(BMI为85 - 95百分位数)和肥胖青少年(BMI≥95百分位数)未来发生ESRD治疗的风险增加,发病率分别为6.08和13.40例/ 10万人-年。在一个调整了性别、原籍国、收缩压和入组时间的多变量模型中,对于全因治疗的ESRD,超重的风险比为3.00 (95% CI, 2.50-3.60),肥胖的风险比为6.89 (95% CI, 5.52-8.59)。超重(HR, 5.96;95% CI, 4.41-8.06)和肥胖(HR, 19.37;95% CI(14.13-26.55)是糖尿病ESRD的独立危险因素。超重正相关(HR, 2.17;95% CI, 1.71-2.74)和肥胖(HR, 3.41;95% CI, 2.42-4.79)与非糖尿病性ESRD也有记录。结论:在25年期间,青少年超重和肥胖与全因治疗ESRD的风险显著增加相关。BMI升高是糖尿病和非糖尿病ESRD的重要危险因素。
{"title":"Body mass index in 1.2 million adolescents and risk for end-stage renal disease.","authors":"Asaf Vivante,&nbsp;Eliezer Golan,&nbsp;Dorit Tzur,&nbsp;Adi Leiba,&nbsp;Amir Tirosh,&nbsp;Karl Skorecki,&nbsp;Ronit Calderon-Margalit","doi":"10.1001/2013.jamainternmed.85","DOIUrl":"https://doi.org/10.1001/2013.jamainternmed.85","url":null,"abstract":"<p><strong>Background: </strong>The relationship between adolescent body mass index (BMI) and future risk for end-stage renal disease (ESRD) is not fully understood, nor is it known the extent to which this association is limited to diabetic ESRD. We evaluated the association between BMI in adolescence and the risk for all-cause, diabetic, and nondiabetic ESRD.</p><p><strong>Methods: </strong>Medical data about 1 194 704 adolescents aged 17 years who had been examined for fitness for military service between January 1, 1967, and December 31, 1997, were linked to the Israeli ESRD registry in this nationwide population-based retrospective cohort study. Incident cases of treated ESRD between January 1, 1980, and May 31, 2010, were included. Cox proportional hazards models were used to estimate the hazard ratio (HR) for treated ESRD among study participants for their BMI at age 17 years, defined in accord with the US Centers for Disease Control and Prevention BMI for age and sex classification.</p><p><strong>Results: </strong>During 30 478 675 follow-up person-years (mean [SD], 25.51 [8.77] person-years), 874 participants (713 male and 161 female) developed treated ESRD, for an overall incidence rate of 2.87 cases per 100 000 person-years. Compared with adolescents of normal weight, overweight adolescents (85th to 95th percentiles of BMI) and obese adolescents (≥95th percentile of BMI) had an increased future risk for treated ESRD, with incidence rates of 6.08 and 13.40 cases per 100 000 person-years, respectively. In a multivariate model adjusted for sex, country of origin, systolic blood pressure, and period of enrollment in the study, overweight was associated with an HR of 3.00 (95% CI, 2.50-3.60) and obesity with an HR of 6.89 (95% CI, 5.52-8.59) for all-cause treated ESRD. Overweight (HR, 5.96; 95% CI, 4.41-8.06) and obesity (HR, 19.37; 95% CI, 14.13-26.55) were strong and independent risk factors for diabetic ESRD. Positive associations of overweight (HR, 2.17; 95% CI, 1.71-2.74) and obesity (HR, 3.41; 95% CI, 2.42-4.79) with nondiabetic ESRD were also documented.</p><p><strong>Conclusions: </strong>Overweight and obesity in adolescents were associated with significantly increased risk for all-cause treated ESRD during a 25-year period. Elevated BMI constitutes a substantial risk factor for diabetic and nondiabetic ESRD.</p>","PeriodicalId":8290,"journal":{"name":"Archives of internal medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2012-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/2013.jamainternmed.85","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31012544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 245
The promise of primary care-based screening for diabetic retinopathy: the devil will be in the details. 以初级保健为基础的糖尿病视网膜病变筛查的前景:细节决定成败。
Pub Date : 2012-11-26 DOI: 10.1001/2013.jamainternmed.406
Lauren Patty Daskivich, Carol M Mangione
{"title":"The promise of primary care-based screening for diabetic retinopathy: the devil will be in the details.","authors":"Lauren Patty Daskivich,&nbsp;Carol M Mangione","doi":"10.1001/2013.jamainternmed.406","DOIUrl":"https://doi.org/10.1001/2013.jamainternmed.406","url":null,"abstract":"","PeriodicalId":8290,"journal":{"name":"Archives of internal medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2012-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/2013.jamainternmed.406","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30946066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
New drug: caution indicated. 新药:需谨慎。
Pub Date : 2012-11-26 DOI: 10.1001/2013.jamainternmed.610
Thomas J Moore
{"title":"New drug: caution indicated.","authors":"Thomas J Moore","doi":"10.1001/2013.jamainternmed.610","DOIUrl":"https://doi.org/10.1001/2013.jamainternmed.610","url":null,"abstract":"","PeriodicalId":8290,"journal":{"name":"Archives of internal medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2012-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/2013.jamainternmed.610","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30960333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Effect of legumes as part of a low glycemic index diet on glycemic control and cardiovascular risk factors in type 2 diabetes mellitus: a randomized controlled trial. 豆类作为低血糖指数饮食的一部分对2型糖尿病患者血糖控制和心血管危险因素的影响:一项随机对照试验
Pub Date : 2012-11-26 DOI: 10.1001/2013.jamainternmed.70
David J A Jenkins, Cyril W C Kendall, Livia S A Augustin, Sandra Mitchell, Sandhya Sahye-Pudaruth, Sonia Blanco Mejia, Laura Chiavaroli, Arash Mirrahimi, Christopher Ireland, Balachandran Bashyam, Edward Vidgen, Russell J de Souza, John L Sievenpiper, Judy Coveney, Lawrence A Leiter, Robert G Josse

Background: Legumes, including beans, chickpeas, and lentils, are among the lowest glycemic index (GI) foods and have been recommended in national diabetes mellitus (DM) guidelines. Yet, to our knowledge, they have never been used specifically to lower the GI of the diet. We have therefore undertaken a study of low-GI foods in type 2 DM with a focus on legumes in the intervention.

Methods: A total of 121 participants with type 2 DM were randomized to either a low-GI legume diet that encouraged participants to increase legume intake by at least 1 cup per day, or to increase insoluble fiber by consumption of whole wheat products, for 3 months. The primary outcome was change in hemoglobin A1c (HbA1c) values with calculated coronary heart disease (CHD) risk score as a secondary outcome.

Results: The low-GI legume diet reduced HbA1c values by -0.5% (95% CI, -0.6% to -0.4%) and the high wheat fiber diet reduced HbA1c values by -0.3% (95% CI, -0.4% to -0.2%). The relative reduction in HbA1c values after the low-GI legume diet was greater than after the high wheat fiber diet by -0.2% (95% CI, -0.3% to -0.1%; P < .001). The respective CHD risk reduction on the low-GI legume diet was -0.8% (95% CI, -1.4% to -0.3%; P = .003), largely owing to a greater relative reduction in systolic blood pressure on the low-GI legume diet compared with the high wheat fiber diet (-4.5 mm Hg; 95% CI, -7.0 to -2.1 mm Hg; P < .001).

Conclusion: Incorporation of legumes as part of a low-GI diet improved both glycemic control and reduced calculated CHD risk score in type 2 DM.

背景:豆类,包括豆类、鹰嘴豆和扁豆,是血糖指数(GI)最低的食物之一,已被推荐到国家糖尿病指南中。然而,据我们所知,它们从未被专门用于降低饮食中的GI值。因此,我们对2型糖尿病患者进行了一项低gi食物的研究,重点是豆类干预。方法:共有121名2型糖尿病患者被随机分为低gi豆类饮食组,鼓励参与者每天至少增加1杯豆类摄入量,或通过食用全麦产品增加不溶性纤维,为期3个月。主要终点是血红蛋白A1c (HbA1c)值的变化,计算冠心病(CHD)风险评分作为次要终点。结果:低gi豆类饮食使HbA1c值降低了-0.5% (95% CI, -0.6%至-0.4%),高小麦纤维饮食使HbA1c值降低了-0.3% (95% CI, -0.4%至-0.2%)。低gi豆类饮食后HbA1c值的相对降低比高小麦纤维饮食后大-0.2% (95% CI, -0.3%至-0.1%;P < 0.001)。低gi豆类饮食的冠心病风险降低率分别为-0.8% (95% CI, -1.4%至-0.3%;P = 0.003),主要是由于与高小麦纤维饮食相比,低gi豆类饮食的收缩压相对降低更大(-4.5 mm Hg;95% CI, -7.0 ~ -2.1 mm Hg;P < 0.001)。结论:将豆类作为低gi饮食的一部分,可以改善2型糖尿病患者的血糖控制并降低计算出的冠心病风险评分。
{"title":"Effect of legumes as part of a low glycemic index diet on glycemic control and cardiovascular risk factors in type 2 diabetes mellitus: a randomized controlled trial.","authors":"David J A Jenkins,&nbsp;Cyril W C Kendall,&nbsp;Livia S A Augustin,&nbsp;Sandra Mitchell,&nbsp;Sandhya Sahye-Pudaruth,&nbsp;Sonia Blanco Mejia,&nbsp;Laura Chiavaroli,&nbsp;Arash Mirrahimi,&nbsp;Christopher Ireland,&nbsp;Balachandran Bashyam,&nbsp;Edward Vidgen,&nbsp;Russell J de Souza,&nbsp;John L Sievenpiper,&nbsp;Judy Coveney,&nbsp;Lawrence A Leiter,&nbsp;Robert G Josse","doi":"10.1001/2013.jamainternmed.70","DOIUrl":"https://doi.org/10.1001/2013.jamainternmed.70","url":null,"abstract":"<p><strong>Background: </strong>Legumes, including beans, chickpeas, and lentils, are among the lowest glycemic index (GI) foods and have been recommended in national diabetes mellitus (DM) guidelines. Yet, to our knowledge, they have never been used specifically to lower the GI of the diet. We have therefore undertaken a study of low-GI foods in type 2 DM with a focus on legumes in the intervention.</p><p><strong>Methods: </strong>A total of 121 participants with type 2 DM were randomized to either a low-GI legume diet that encouraged participants to increase legume intake by at least 1 cup per day, or to increase insoluble fiber by consumption of whole wheat products, for 3 months. The primary outcome was change in hemoglobin A1c (HbA1c) values with calculated coronary heart disease (CHD) risk score as a secondary outcome.</p><p><strong>Results: </strong>The low-GI legume diet reduced HbA1c values by -0.5% (95% CI, -0.6% to -0.4%) and the high wheat fiber diet reduced HbA1c values by -0.3% (95% CI, -0.4% to -0.2%). The relative reduction in HbA1c values after the low-GI legume diet was greater than after the high wheat fiber diet by -0.2% (95% CI, -0.3% to -0.1%; P < .001). The respective CHD risk reduction on the low-GI legume diet was -0.8% (95% CI, -1.4% to -0.3%; P = .003), largely owing to a greater relative reduction in systolic blood pressure on the low-GI legume diet compared with the high wheat fiber diet (-4.5 mm Hg; 95% CI, -7.0 to -2.1 mm Hg; P < .001).</p><p><strong>Conclusion: </strong>Incorporation of legumes as part of a low-GI diet improved both glycemic control and reduced calculated CHD risk score in type 2 DM.</p>","PeriodicalId":8290,"journal":{"name":"Archives of internal medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2012-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/2013.jamainternmed.70","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30997274","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 321
Prevalence and predictors of smoking by inpatients during a hospital stay. 住院病人在住院期间吸烟的患病率和预测因素。
Pub Date : 2012-11-26 DOI: 10.1001/2013.jamainternmed.300
Susan Regan, Joseph C Viana, Michele Reyen, Nancy A Rigotti

Background: Accredited US hospitals prohibit smoking inside hospital buildings. Patients are expected to abstain from smoking throughout their hospitalization, but how many do so is unclear. Smoking by inpatients may compromise patient safety, clinical outcomes, and hospital efficiency.

Methods: We conducted an observational study of adult cigarette smokers visited by a tobacco counselor while hospitalized and reached for telephone follow-up in the 2 weeks after discharge. We assessed smoking during the hospital stay at the time of counseling for all patients and at follow-up for those reached. We used generalized linear models to estimate adjusted relative risk (ARR) for smoking while hospitalized, adjusted by patient and admission characteristics.

Results: From May 1, 2007, through April 31, 2010, counselors visited 5399 smokers, of whom 14.9% had smoked between admission and the visit. Of 3555 eligible smokers who consented to follow-up, 2185 were reached. Smoking at any time during the hospitalization was reported by 18.4%, less often during winter months than the rest of the year (14.4% vs 19.7%, P = .007). Smoking at any time while hospitalized was less common among those 50 years or older (ARR, 0.74; 95% CI, 0.62-0.88), those admitted to a cardiac unit (0.64; 0.51-0.81), and those intending to quit after discharge (0.46; 0.34-0.63) and more common among those with longer stays (1.36; 1.14-1.62) and those experiencing cigarette cravings (moderate: 1.23; 1.14-1.33; severe: 1.25; 1.18-1.34). Nicotine replacement therapy ordered the day of admission was associated with less smoking before the counselor's visit (ARR, 0.83; 95% CI, 0.72-0.96) but not for the entire hospital stay.

Conclusions: Nearly one-fifth of smokers admitted to a smoke-free hospital smoked during their hospital stay. Ordering nicotine replacement therapy routinely at admission and ongoing monitoring of patients' cigarette cravings might reduce smoking among admitted patients.

背景:经过认证的美国医院禁止在医院建筑内吸烟。病人应该在住院期间戒烟,但有多少人这样做尚不清楚。住院患者吸烟可能危及患者安全、临床结果和医院效率。方法:我们对成年吸烟者进行了观察性研究,这些吸烟者在住院期间接受了烟草咨询师的拜访,并在出院后2周内进行了电话随访。我们评估了所有患者在住院期间的吸烟情况,并对他们进行了咨询和随访。我们使用广义线性模型来估计住院期间吸烟的调整相对危险度(ARR),并根据患者和住院特征进行调整。结果:从2007年5月1日到2010年4月31日,咨询师访问了5399名吸烟者,其中14.9%的人在入院和访问期间吸烟。在同意随访的3555名符合条件的吸烟者中,有2185人接受了随访。住院期间任何时间吸烟的报告比例为18.4%,冬季月份的吸烟率低于其他月份(14.4% vs 19.7%, P = 0.007)。住院期间任何时间吸烟在50岁及以上的患者中较少见(ARR, 0.74;95% CI, 0.62-0.88),入住心脏科的患者(0.64;(0.51 ~ 0.81),出院后打算戒烟者(0.46;0.34-0.63),在停留时间较长的人群中更为常见(1.36;1.14-1.62)和那些有吸烟欲望的人(中度:1.23;1.14 - -1.33;严重:1.25;1.18 - -1.34)。入院当天安排的尼古丁替代疗法与咨询师来访前吸烟减少相关(ARR, 0.83;95% CI, 0.72-0.96),但在整个住院期间并非如此。结论:近五分之一住进无烟医院的吸烟者在住院期间吸烟。在入院时常规安排尼古丁替代疗法,并持续监测患者对香烟的渴望,可能会减少入院患者的吸烟率。
{"title":"Prevalence and predictors of smoking by inpatients during a hospital stay.","authors":"Susan Regan,&nbsp;Joseph C Viana,&nbsp;Michele Reyen,&nbsp;Nancy A Rigotti","doi":"10.1001/2013.jamainternmed.300","DOIUrl":"https://doi.org/10.1001/2013.jamainternmed.300","url":null,"abstract":"<p><strong>Background: </strong>Accredited US hospitals prohibit smoking inside hospital buildings. Patients are expected to abstain from smoking throughout their hospitalization, but how many do so is unclear. Smoking by inpatients may compromise patient safety, clinical outcomes, and hospital efficiency.</p><p><strong>Methods: </strong>We conducted an observational study of adult cigarette smokers visited by a tobacco counselor while hospitalized and reached for telephone follow-up in the 2 weeks after discharge. We assessed smoking during the hospital stay at the time of counseling for all patients and at follow-up for those reached. We used generalized linear models to estimate adjusted relative risk (ARR) for smoking while hospitalized, adjusted by patient and admission characteristics.</p><p><strong>Results: </strong>From May 1, 2007, through April 31, 2010, counselors visited 5399 smokers, of whom 14.9% had smoked between admission and the visit. Of 3555 eligible smokers who consented to follow-up, 2185 were reached. Smoking at any time during the hospitalization was reported by 18.4%, less often during winter months than the rest of the year (14.4% vs 19.7%, P = .007). Smoking at any time while hospitalized was less common among those 50 years or older (ARR, 0.74; 95% CI, 0.62-0.88), those admitted to a cardiac unit (0.64; 0.51-0.81), and those intending to quit after discharge (0.46; 0.34-0.63) and more common among those with longer stays (1.36; 1.14-1.62) and those experiencing cigarette cravings (moderate: 1.23; 1.14-1.33; severe: 1.25; 1.18-1.34). Nicotine replacement therapy ordered the day of admission was associated with less smoking before the counselor's visit (ARR, 0.83; 95% CI, 0.72-0.96) but not for the entire hospital stay.</p><p><strong>Conclusions: </strong>Nearly one-fifth of smokers admitted to a smoke-free hospital smoked during their hospital stay. Ordering nicotine replacement therapy routinely at admission and ongoing monitoring of patients' cigarette cravings might reduce smoking among admitted patients.</p>","PeriodicalId":8290,"journal":{"name":"Archives of internal medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2012-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/2013.jamainternmed.300","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31030516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 31
Recognition of Lyme in time. 及时识别莱姆病。
Pub Date : 2012-11-26 DOI: 10.1001/2013.jamainternmed.685
Jeffrey A Tabas
{"title":"Recognition of Lyme in time.","authors":"Jeffrey A Tabas","doi":"10.1001/2013.jamainternmed.685","DOIUrl":"https://doi.org/10.1001/2013.jamainternmed.685","url":null,"abstract":"","PeriodicalId":8290,"journal":{"name":"Archives of internal medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2012-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/2013.jamainternmed.685","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30945326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnosing lyme disease: getting the details right. 诊断莱姆病:获得正确的细节。
Pub Date : 2012-11-26 DOI: 10.1001/archinternmed.2012.4003
Jonathan A Edlow
{"title":"Diagnosing lyme disease: getting the details right.","authors":"Jonathan A Edlow","doi":"10.1001/archinternmed.2012.4003","DOIUrl":"https://doi.org/10.1001/archinternmed.2012.4003","url":null,"abstract":"","PeriodicalId":8290,"journal":{"name":"Archives of internal medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2012-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/archinternmed.2012.4003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30947035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Stability of active ingredients in long-expired prescription medications. 长期过期处方药中有效成分的稳定性。
Pub Date : 2012-11-26 DOI: 10.1001/archinternmed.2012.4501
Lee Cantrell, Jeffrey R Suchard, Alan Wu, Roy R Gerona
{"title":"Stability of active ingredients in long-expired prescription medications.","authors":"Lee Cantrell,&nbsp;Jeffrey R Suchard,&nbsp;Alan Wu,&nbsp;Roy R Gerona","doi":"10.1001/archinternmed.2012.4501","DOIUrl":"https://doi.org/10.1001/archinternmed.2012.4501","url":null,"abstract":"","PeriodicalId":8290,"journal":{"name":"Archives of internal medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2012-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/archinternmed.2012.4501","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30960669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 49
期刊
Archives of internal medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1